Anaplastic Lymphoma Kinase Rearrangement and Response to Crizotinib in Pancreatic Ductal Adenocarcinoma

被引:9
|
作者
Tuli, Richard [1 ]
Lo, Simon [1 ]
Koo, Jaimie [1 ]
Pishvaian, Michael [2 ]
Bender, R. Joseph [2 ]
Petricoin, Emanuel [2 ]
Brody, Jonathan [2 ]
Nissen, Nicholas [1 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Perthera, Mclean, VA USA
关键词
D O I
10.1200/PO.17.00016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [21] Dissecting the clinicopathologic, genomic, and prognostic significance of anaplastic lymphoma kinase rearrangement in resected lung adenocarcinoma
    Cao, Hang
    Zhu, Wangyang
    Tang, Huatao
    Deng, Chaoqiang
    Fu, Fangqiu
    Li, Yuan
    Zhang, Yang
    Chen, Haiquan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2025, 169 (04):
  • [23] Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase - Positive Anaplastic Large Cell Lymphoma
    Xu, Wendan
    Kim, Ji-Won
    Jung, Woo June
    Koh, Youngil
    Yoon, Sung-Soo
    CANCER RESEARCH AND TREATMENT, 2018, 50 (02): : 599 - 613
  • [24] An Anaplastic Lymphoma Kinase Immunohistochemistry-Negative but Fluorescence In Situ Hybridization-Positive Lung Adenocarcinoma Is Resistant to Crizotinib
    Shi, Ruoshi
    Varella-Garcia, Marileila
    Li, Ming
    Ludkovski, Olga
    Danesh, Arnavaz
    Ng, Christine
    Pham, Nhu-An
    Pugh, Trevor
    Shepherd, Frances A.
    Tsao, Ming-Sound
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (12) : 2248 - 2252
  • [25] Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening
    Lee, Jeeyun
    Kim, Hee Cheol
    Hong, Jung Yong
    Wang, Kai
    Kim, Sun Young
    Jang, Jiryeon
    Kim, Seung Tae
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Young Suk
    Lee, Jiyun
    Lee, Woo Yong
    Park, Yoon Ah
    Huh, Jung Wook
    Yun, Seong Hyeon
    Do, In-Gu
    Kim, Seok Hyung
    Balasubramanian, Sohail
    Stephens, Philip J.
    Ross, Jeffrey S.
    Li, Gang Gary
    Hornby, Zachary
    Ali, Siraj M.
    Miller, Vincent A.
    Kim, Kyoung-Mee
    Ou, Sai-Hong Ignatius
    ONCOTARGET, 2015, 6 (27) : 24320 - 24332
  • [26] Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement
    Nakajima, Naoki
    Yoshizawa, Akihiko
    Kondo, Kyoko
    Rokutan-Kurata, Mariyo
    Hirata, Masahiro
    Furuhata, Ayako
    Sumiyoshi, Shinji
    Sonobe, Makoto
    Menju, Toshi
    Momose, Masanobu
    Fujimoto, Masakazu
    Date, Hiroshi
    Haga, Hironori
    HISTOPATHOLOGY, 2017, 71 (01) : 143 - 149
  • [27] Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers
    Ma, De-Ning
    Gao, Xin-Yi
    Dan, Yi-Bo
    Zhang, An-Ni
    Wang, Wei-Jun
    Yang, Guang
    Zhu, Hong-Zhou
    ONCOTARGETS AND THERAPY, 2020, 13 : 6927 - 6935
  • [28] Metastatic Anaplastic Lymphoma Kinase Rearrangement-Positive Adenocarcinoma of Occult Primary Mimicking Ovarian Cancer
    Chahin, Michael
    Krishnan, Nithya
    Matthews-Hew, Trevanne
    Hew, Jason
    Pham, Dat
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
  • [29] Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: A case report
    Kothari S.
    Ud-Din N.
    Lisi M.
    Coyle T.
    Journal of Medical Case Reports, 10 (1)
  • [30] Complete Response of Anaplastic Lymphoma Kinase-Mutated Refractory Extranodal Natural Killer/T-Cell Lymphoma to Crizotinib
    Thanarajasingam, Gita
    Edell, Eric S.
    Markovic, Svetomir M.
    MAYO CLINIC PROCEEDINGS, 2016, 91 (09) : 1319 - 1320